| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -3e-05 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 1.8e-05 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -4.1e-05 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 5.3e-05 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |